Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Breast Diseases × Anastrozole × Clear all

Phase

Status

Active not recruiting 3 Unknown 1 Recruiting 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 24 Advanced Breast Cancer 2 Vitamin D Deficiency 1 Triple Negative Breast Neoplasms 1 Recurrence 1 Obesity 1 Nutrition Disorders 1 Neoplasm Metastasis 1 Inflammatory Breast Neoplasms 1 Endometrial Neoplasms 1 Carcinoma, Intraductal, Noninfiltrating 1 Carcinoma 1 Camurati-Engelmann Syndrome 1 Bulbo-Spinal Atrophy, X-Linked 1 Breast Diseases 1 Breast Carcinoma In Situ 1 Breast Cancer Organoids 1

Interventions

pyrotinib 3 Docetaxel 3 Trastuzumab 2 Letrozole 2 Epirubicin 2 Doxorubicin 2 Cyclophosphamide 2 Capecitabine 2 palbociclib 1 exemestane 1 Vinorelbine 1 Tomography, X-Ray Computed 1 Tamoxifen 1 Surgimend 1 Sodium Chloride 1 Paclitaxel 1 Mammaplasty 1 Liquid Biopsy 1 Lapatinib 1 Goserelin 1 Drug Therapy 1 Drug Evaluation 1 Cryotherapy 1 Carboplatin 1 Botulinum Toxins, Type A 1 Aromatase Inhibitors 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03910712 2019-04-10

Pyrotinib

Peking Union Medical College Hospital

Phase 2 Unknown

Breast Diseases, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡